Skip Nav Destination
Article navigation
1 May 2022
Research Watch|
May 02 2022
Coblockade of TIGIT and PD-1 Optimizes Antitumor CD8+ T-cell Response
Online Issn: 2159-8290
Print Issn: 2159-8274
©2022 American Association for Cancer Research.
2022
American Association for Cancer Research.
Cancer Discov (2022) 12 (5): 1182.
- Views Icon Views
- Share Icon Share
-
Tools Icon
Tools
- Search Site
-
Article Versions Icon
Versions
- Version of Record May 2 2022
- Proof March 25 2022
Citation
Coblockade of TIGIT and PD-1 Optimizes Antitumor CD8+ T-cell Response. Cancer Discov 1 May 2022; 12 (5): 1182. https://doi.org/10.1158/2159-8290.CD-RW2022-050
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionPay-Per-View Access
$50.00
133
Views
0
Citations
Citing articles via
Advertisement